Drug maker Bristol Myers Squibb Co. (BMY) announced Monday positive and promising data from the trials in Hematology pipeline, comprising Iberdomide, Golcadomide, BCL6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback